drugset / Trial / NCT02112643
Selenium in Mild Thyroid Eye Disease in North America
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether sodium selenite is helpful in the treatment of mild thyroid eye disease in North America.
Timeline
- Start
- 2015-10
- Primary completion
- 2016-11-16
- Completion
- 2016-11-16
Outcome
Outcome not reported
Stopped (Business): “Lack of funding”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium selenate | Small molecule | 100 ug | Oral |